{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:49:17Z","timestamp":1768513757987,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":2626,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Visceral Surgery"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jviscsurg.2014.01.009","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T06:30:35Z","timestamp":1395124235000},"page":"125-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Peri-operative management of anticoagulation and antiplatelet therapy in gastrointestinal surgery"],"prefix":"10.1016","volume":"151","author":[{"given":"S.-E.","family":"Degirmenci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Steib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0005","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.annfar.2005.05.009","article-title":"Pr\u00e9vention de la maladie thromboembolique veineuse, chirurgie digestive et de varices","volume":"24","author":"Steib","year":"2005","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0010","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.annfar.2011.10.008","article-title":"Pr\u00e9vention de la maladie thromboembolique veineuse postop\u00e9ratoire. Actualisation 2011. Texte court","volume":"30","author":"Samama","year":"2011","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.beha.2008.12.001","article-title":"Epidemiology of cancer-related venous thromboembolism","volume":"22","author":"Wun","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0020","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1160\/TH03-03-0152","article-title":"Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures","volume":"90","author":"White","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.sla.0000193959.44677.48","article-title":"A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project","volume":"243","author":"Agnelli","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0030","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archinte.168.12.1261","article-title":"Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis","volume":"168","author":"Akl","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0035","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0040","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/bjs.5154","article-title":"Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery","volume":"92","author":"Agnelli","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0045","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/j.1538-7836.2007.02657.x","article-title":"Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison","volume":"5","author":"Turpie","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0050","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence based clinical practice guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9490","article-title":"Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis","volume":"9","author":"Roderick","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0060","first-page":"1","article-title":"Elastic compression stockings for prevention of deep vein thrombosis (review)","volume":"Issue 7","author":"Sachdeva","year":"2010","journal-title":"Cochrane Library"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0065","first-page":"1","article-title":"Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients (review)","volume":"Issue 4","author":"Kakkos","year":"2008","journal-title":"Cochrane Library"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0070","first-page":"CD004318","article-title":"Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery","volume":"1","author":"Rasmussen","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0075","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1538-7836.2010.03892.x","article-title":"Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study","volume":"6","author":"Kakkar","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0080","series-title":"Pr\u00e9vention du risque thromboembolique apr\u00e8s une intervention pour cancer abdomino-pelvien (\u00e9tude PREOS). Abstract R454","author":"Samama","year":"2011"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0085","first-page":"291","article-title":"Fatal venous thromboembolism after splenectomy: pathogenesis and management","volume":"112","author":"Ha","year":"2012","journal-title":"JAOA"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0090","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJMoa0901836","article-title":"Perioperative safety in the longitudinal assessment of bariatric surgery. The longitudinal assessment of bariatric surgery (LABS consortium)","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.soard.2010.12.008","article-title":"Venous thromboembolism after bariatric surgery performed by bariatric surgery center of excellence participants: analysis of the bariatric outcomes longitudinal database","volume":"7","author":"Winegar","year":"2011","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1381\/096089202321144522","article-title":"A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery","volume":"12","author":"Scholten","year":"2002","journal-title":"Obes Surg"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0105","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1381\/09608920160558588","article-title":"Prophylaxis of venous thromboembolism using two different doses molecular-weight heparin (nadroparin) in bariatric surgery: a pros randomized trial","volume":"11","author":"Kalfarentzos","year":"2001","journal-title":"Obes Surg"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11695-007-9381-y","article-title":"Anti-Xa in bariatric surgery patients receiving prophylactic enoxaparin","volume":"18","author":"Rowan","year":"2008","journal-title":"Obes Surg"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0115","first-page":"515","article-title":"Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery","volume":"110","author":"Simone","year":"2013","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.soard.2007.11.010","article-title":"Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification and antifactor Xa activity","author":"Borkgren-Ojonek","year":"2008","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0125","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.thromres.2009.04.021","article-title":"Pharmacodynamics of LMWH in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study)","volume":"124","author":"Imberti","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0130","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1007\/s00464-008-0031-9","article-title":"The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial","volume":"22","author":"Raftopoulos","year":"2008","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0135","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.soard.2010.02.046","article-title":"Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery","volume":"6","author":"Magle","year":"2010","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0140","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/SLA.0b013e3182519ccf","article-title":"Identifying patients at high risk for venous thromboembolism requiring treatment after out patient surgery","volume":"255","author":"Pannucci","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0145","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0150","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0155","series-title":"Bon usage des agents antiplaquettaires","author":"HAS recommandations","year":"2012"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0160","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/hrt.2011.224519","article-title":"Non-cardiac surgery in patients with coronary stents: the RECO study","volume":"97","author":"Albaladejo","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0165","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/bja\/aer274","article-title":"Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled STRATAGEM trial","volume":"107","author":"Mantz","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0170","first-page":"334","volume":"69","author":"Grines","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0175","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/EJA.0b013e32833f6f6f","article-title":"Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology","volume":"27","author":"Gogarten","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/EJA.0b013e32834050ab","article-title":"Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy","volume":"28","author":"Weber","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0185","unstructured":"HAS 2008 Recommandations. Prise en charge des surdosages en antivitamines des situations \u00e0 risque h\u00e9morragique et des accidents h\u00e9morragiques chez les patients trait\u00e9s par antivitamines K en ville et en milieu hospitalier."},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0190","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.amjcard.2012.03.049","article-title":"Meta-analysis of efficacy and safety of new oral anticoagulants (Dabigatran, Rivoroxaban, Apixaban) versus warfarin in patients with atrial fibrillatoin","volume":"110","author":"Miller","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0195","first-page":"812","article-title":"Assessment of laboratory assays to measure rivaroxaban-an oral, direct factor Xa inhibitor","volume":"103","author":"Samama","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0200","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.acvd.2011.09.001","article-title":"Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study group on Thrombosis and Haemostasis","volume":"104","author":"Si\u00e9","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0205","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-010249","article-title":"Uncontrollable haemorrhage following dabigatran prophylaxis","author":"Sandhu","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0210","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1160\/TH12-05-0319","article-title":"New direct oral anticoagulants \u2013 current therapeutic options and treatment recommendations for bleeding complications","volume":"108","author":"Miesbach","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0215","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/eurheartj\/ehs408","article-title":"Acute management of bleeding in patients on novel oral anticoagulants","volume":"34","author":"Siegal","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0220","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/ALN.0b013e318289bcba","article-title":"Managing new oral anticoagulants in the perioperative and intensive care unit setting","volume":"118","author":"Levy","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0225","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1160\/TH12-11-0868","article-title":"The perioperative management of new direct oral anticoagulants: a question without answers","volume":"110","author":"Ferrandis","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.acvd.2013.04.009","article-title":"Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the Working group on perioperative Haemostasis (GIHP)- March 2013","author":"Pernod","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0235","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0240","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0245","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1160\/TH11-06-0391","article-title":"Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls","volume":"107","author":"Samama","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0250","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1160\/TH11-11-0804","article-title":"Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring dabigatran etexilate","volume":"107","author":"Douxfils","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0255","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.thromres.2012.09.004","article-title":"Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature","volume":"130","author":"Douxfils","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0260","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/ALN.0b013e318238c036","article-title":"Evaluation of the prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in the rabbit model","volume":"116","author":"Godier","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0265","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","article-title":"Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects","volume":"124","author":"Eerenberg","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1160\/TH12-03-0179","article-title":"Effect of non-specific reversal agents on anticoagulant activity of dabogatran and rivaroxaban. A randomised crossover ex vivo study in healthy volunteers","volume":"108","author":"Marlu","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jviscsurg.2014.01.009_bib0275","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.3102","article-title":"A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa","volume":"19","author":"Lu","year":"2013","journal-title":"Nat Med"}],"container-title":["Journal of Visceral Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878788614000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878788614000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:30:16Z","timestamp":1761809416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878788614000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1878788614000101"],"URL":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2014.01.009","relation":{},"ISSN":["1878-7886"],"issn-type":[{"value":"1878-7886","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peri-operative management of anticoagulation and antiplatelet therapy in gastrointestinal surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Visceral Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2014.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}